Biological E

What sets Qdenga apart is that it can be administered regardless of a prior infection. A phased rollout could take place as early as this year

Despite significant annual allocations for India's National Immunisation Programme, a substantial portion of funds remains unspent, raising concerns about implementation efficiency. While vaccine coverage has improved, RTI data reveals consistent spending shortfalls, highlighting a need for better fund utilization and accountability in this crucial public health initiative.

As the country grapples with the second wave of Covid-19, vaccine maker biological e is gearing up to churn out 75 to 80 million doses per month of its recombinant protein vaccine candidate from Aug. The company also says it will be one of the most affordable vaccines in the country. The subunit vaccine, which is modelled after the hepatitis B vaccine, uses traditional technology.

In a strategic move, Hyderabad-based pharma & biologics player biological e Limited (BE) has acquired Akorn India Limited, a subsidiary of US-based Akorn Inc for $10 million (Rs 75 crore approx.).

Biopharma player biological e has joined hands with Canadian player Providence Therapeutics Holdings Inc for licencing the latter’s mRNA vaccine PTX-COVID-19-B

The vaccine, which is currently undergoing phase-3 clinical trials, will likely to be available in the next few months, the health ministry said in a statement. These vaccine doses will be manufactured and stockpiled by Biological-E from August-December 2021.

biological e's Covid vaccine, Corbevax, has received WHO emergency use listing, following approval in India. The vaccine, developed on the protein sub-unit platform, received authorization for various age groups, including use as a booster. The Hyderabad-based company has supplied 100 million doses to India, emphasizing its commitment to affordable and accessible vaccines. The WHO listing enhances global accessibility to Corbevax, contributing to broader immunization efforts. "Our commitment is to provide affordable and accessible vaccines that are of high quality and the WHO EUL lays a path for us to make that possible," biological e managing director Mahima Datla said.

With the Union government gearing up to roll out the Covid vaccination drive for the children in the age group of 12-14 years on Wednesday, the district health department has identified 1.02 lakh beneficiaries to be inoculated.

Homegrown biopharmaceutical company biological e (BioE) and European biotech company Valneva SE (Valneva) announced that the World Health Organization (WHO) has awarded its Japanese Encephalitis vaccine prequalification for global use in adults.

Takeda and biological e Limited have partnered to manufacture up to 50 million doses per year of the dengue vaccine QDENGA, with the goal of delivering 100 million doses by 2030. The collaboration aims to make the vaccine widely accessible and combat dengue on a global scale.

Texan developers of biological e’s new Covid shot, Corbevax, have focused on ending vaccine apartheid

Vaccine maker biological e Limited (BE) on Friday said it has received approval from the Drugs Controller General of India (DCGI) to manufacture and commercialise its 14-valent paediatric pneumococcal conjugate vaccine (PCV14) against S pneumoniae infection.

Drugs Controller General of India (DCGI) grants final approval to biological e's COVID-19 vaccine Corbevax, for children between 12-18 years of age, news agency ANI reported on Monday.

Bharat Biotech and biological e are expecting a revival in demand for their Covid vaccines in other countries due to newer omicron variants. Both these Hyderabad-based firms have been sitting on huge stocks of unutilised vaccines due to a slump in demand as cases receded while biological e has 20 crore doses of Corbevax in filled form. Bharat Biotech has 5 crore doses of Covaxin in vials and 20 crore doses as substance. "Fresh stocks are ready for supplies additional production capacity is also available," Bharat Biotech said. biological e CEO Mahima Datla told TOI that of the 30 crore doses of finished vaccine it has already supplied 10 crore doses. "The increase in cases globally indicates that Covid is not over yet, however we as a country are prepared to tackle any situation currently we have 20 crore doses in filled form. We are hopeful of receiving the orders." Datla added.

biological e has applied to the World Health Organisation (WHO) for EUL (emergency use listing) of its recombinant protein sub-unit vaccine Corbevax. The company expects to begin supplies of the vaccine to the Indian government soon, biological e MD Mahima Datla told TOI during an exclusive interaction.

Vaccine maker biological e has begun at risk manufacturing of its recombinant protein Covid-19 vaccine – Corbevax that it is developing in tie-up with Texas-based Baylor College of Medicine (BCM), TOI has learnt.

Hyderabad, Jun 26 () Takeda Pharmaceutical Company and biological e Ltd (BE) have signed two licensing agreements for development and delivery of affordable combination vaccines for low and middle-income countries.

On a day Tamil Nadu reported 824 new Covid-19 cases a drop from 892 new cases on Thursday government vaccination centres started providing the Centre-approved Hyderabad-based biological e’s protein sub-unit vaccine Corbevax, as a heterologous booster for adults.

Even as the Telangana government is staring at Covid-19 vaccine shortages, the irony is that two key Indian vaccine makers based out of Hyderabad - Bharat Biotech and biological e - are sitting on vaccine stocks running into crores of doses, some of which may be expiring soon and may have to discarded if unutilised.

Leading Indian vaccines company announced an agreement to form a 50:50 joint venture for the early stage research and development of a six-in-one combination pediatric vaccine to help protect children in India and other developing countries from polio.

biological e Limited (BE) on Monday said it is reducing the price of its Covid-19 vaccine Corbevax to Rs 250 per dose (inclusive of GST but excluding administration charges) from Rs 840 per dose (inclusive of GST) for private vaccination centres. With this, the price of the RBD protein subunit vaccine for the end user along with vaccine administration charges would add up to Rs 400 per dose.

The partnership reinforces the commitment of both companies to support the World Health Organisation's (WHO) global polio eradication programme.

In a major validation of Hyderabad's growing clout as a global vaccine hub, World Health Organisation (WHO) is setting up an mRNA vaccine hub in Hyderabad as part of its plans to set up such hubs in select locations globally, industries minister KT Rama Rao disclosed on Tuesday.

Covid vaccination for the 12-14 age group has begun from March 16 in the district, which has 1.09 lakh children in this eligible bracket. And 64,111 or 58.77% of them have been vaccinated as of now. Also, 30.61% of them got the second dose.

The Union health ministry has decided to make an advance payment of Rs 1,500 crore to biological e’s to reserve 30 crore doses of its recombinant protein subunit vaccine Corbevax.